Patents by Inventor Tim Illidge

Tim Illidge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190192655
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Application
    Filed: September 5, 2018
    Publication date: June 27, 2019
    Inventors: ROSS A. STEWART, MICHELLE MORROW, ROBERT W. WILKINSON, EDMUND POON, SIMON DOVEDI, TIM ILLIDGE
  • Patent number: 10092645
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: October 9, 2018
    Assignee: MedImmune Limited
    Inventors: Ross Stewart, Michelle Morrow, Robert Wilkinson, Edmund Poon, Simon Dovedi, Tim Illidge
  • Publication number: 20160051672
    Abstract: This application provides a method of treating cancer in a patient comprising administering at least one dose of radiation therapy and at least one PD-1 and/or PD-L1 antagonist, wherein at least one PD-1 and/or PD-L1 antagonist is administered on the same day as a dose of radiation therapy or up to and including 4 days later.
    Type: Application
    Filed: June 16, 2015
    Publication date: February 25, 2016
    Inventors: Ross STEWART, Michelle Morrow, Robert Wilkinson, Edmund Poon, Simon Dovedi, Tim Illidge